Patents by Inventor Taku Okazaki

Taku Okazaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOSUPPRESSANT
    Publication number: 20220227887
    Abstract: An immunosuppressant containing a bispecific molecule including a first binding site that specifically binds to LAG3 and a second binding site that specifically binds to CD3 or CD8.
    Type: Application
    Filed: June 10, 2020
    Publication date: July 21, 2022
    Applicants: ONO PHARMACEUTICAL CO., LTD., TOKUSHIMA UNIVERSITY
    Inventors: Taku OKAZAKI, Daisuke SUGIURA, II-mi OKAZAKI, Shiro SHIBAYAMA
  • IMMUNOSUPPRESIVE AGENT
    Publication number: 20220025051
    Abstract: An immunosuppressive agent containing a substance that is selected from anti-CD80 antibodies and anti-PD-L1 antibodies and that promotes binding between PD-L1 and PD-1.
    Type: Application
    Filed: December 6, 2019
    Publication date: January 27, 2022
    Applicants: ONO PHARMACEUTICAL CO., LTD., TOKUSHIMA UNIVERSITY
    Inventors: Taku OKAZAKI, Daisuke SUGIURA, Takeo MAEDA, Shiro SHIBAYAMA
  • Method of screening remedy for heart disease and medicinal composition for treating heart disease
    Patent number: 7407767
    Abstract: A method for screening a substance that inhibits the onset of anti-cardiac troponin I autoantibody-related disease, a pharmaceutical composition and a base material for therapy of cardiac disease that contains the substance obtained by aforesaid method thereof, a therapeutic apparatus that removes anti-troponin I autoantibody for aforesaid antibody related disease, a method of making an animal model for evaluating cardiac disease characterized by administrating anti-cardiac troponin I antibody, a method of selection of a therapeutic substance for cardiac disease characterized by using aforesaid animals, and a diagnosis of dilated cardiomyopathy characterized by measuring anti-cardiac troponin I autoantibody. An apparatus of the present invention that removes anti-cardiac troponin I antibody and a pharmaceutical composition for therapy of the antibody related disease may be useful for a therapy and/or prevention of cardiac disease.
    Type: Grant
    Filed: April 15, 2004
    Date of Patent: August 5, 2008
    Assignees: Ono Pharmaceutical Co., Ltd.
    Inventors: Tasuku Honjo, Taku Okazaki
  • Method of screening remedy for heart disease and medicinal composition for treating heart disease
    Publication number: 20060246525
    Abstract: A method for screening a substance that inhibits the onset of anti-cardiac troponin I autoantibody-related disease, a pharmaceutical composition and a base material for therapy of cardiac disease that contains the substance obtained by aforesaid method thereof, a therapeutic apparatus that removes anti-troponin I autoantibody for aforesaid antibody related disease, a method of making an animal model for evaluating cardiac disease characterized by administrating anti-cardiac troponin I antibody, a method of selection of a therapeutic substance for cardiac disease characterized by using aforesaid animals, and a diagnosis of dilated cardiomyopathy characterized by measuring anti-cardiac troponin I autoantibody. An apparatus of the present invention that removes anti-cardiac troponin I antibody and a pharmaceutical composition for therapy of the antibody related disease may be useful for a therapy and/or prevention of cardiac disease.
    Type: Application
    Filed: April 15, 2004
    Publication date: November 2, 2006
    Inventors: Tasuku Honjo, Taku Okazaki